🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Recruitingn/aAges 18 Years - anyAllLuzerner Kantonsspital
NCT06075602 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of the COMPLEX Registry is to prospectively and retrospectively collect baseline, clinical and procedural data of patients who have undergone PCI or CABG for complex and/ or calcified chronic CAD, irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. The outcomes will be compared in different clinical subgroups (e.g. PCI vs. CABG). The impact of current PCI techniques/ devices, but also CABG strategies in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Subject \>18 years of age * Individuals presenting with chronic, complex and/or calcified CAD and requiring PCI or CABG * Complex coronary artery disease / lesions must include at least one of the following attributes: * Long and/ or heavily calcified coronary lesions * In-stent restenosis * Chronic total occlusions (CTO) * Left main lesions * Bifurcation lesions * Bypass graft lesions * Small vessel disease / coronary microvascular dysfunction (e.g. not amenable to PCI) * Subjects must be willing to sign a patient informed consent (PIC) or must have signed the General Consent (GK). Exclusion Criteria: The presence of any one of the following exclusion criteria will lead to exclusion of the patient. * Patient is \<18 years of age * Patient unwilling or unable to provide informed consent * Patients with no complex and calcified CAD
💊

What it tests

  • Impact of current PCI techniques/ devices in complex coronary artery lesions
📍

Where

1 site
Lucerne Heart Centre
Lucerne, Switzerland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy